The 35th CINP World Congress of Neuropsychopharmacology

Session information

[CINP2024] Short Communications

CINP2024 » Short Communications

Short Communications 18
Others 1

Sat. May 25, 2024 1:00 PM - 2:15 PM Room 9 (G404)

Chair: Hiroko Kotajima (Tokyo Metropolitan Institute of Medical Science)

*Martine Skumlien1,2, Tom P Freeman1, Daniel Hall3, Claire Mokrysz3, Matthew B Wall3,4,5, Shelan Ofori3, Kat Petrilli1, Katie Trinci3, Anna Borissova3,6, Natalia Fernandez-Vinson3, Christelle Langley2,7, Barbara J Sahakian2,7, H Valerie Curran3, Will Lawn3,6,8 (1. Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK, 2. Department of Psychiatry, University of Cambridge, Cambridge, UK , 3. Clinical Psychopharmacology Unit, Clinical Educational and Health Psychology Department, University College London, London, UK , 4. Invicro, London, UK, 5. Faculty of Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK, 6. School of Mental Health and Psychological Sciences, Institute of Psychiatry Psychology and Neuroscience, King’s College London, London, UK, 7. Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK, 8. Department of Addictions, Institute of Psychiatry Psychology and Neuroscience, King’s College London, London, UK)

*Bronislav Jurásek1, Magdalena Vágnerová1,2, Hana Walaská1, Kristýna Mazochová3, Martin Kuchař1 (1. Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of chemistry and technology in Prague, Prague, Czech Republic, 2. Department of Analytical Chemistry, University of chemistry and technology in Prague, Prague, Czech Republic, 3. Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic)

×

Authentication

×

Please log in with your participant account.
» Participant Log In